Switch theme
Sign up to access all valuation multiples
Orion Oyj is a globally operating Finnish pharmaceutical company that develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients. The company predominantly focuses on treatments for central nervous system disorders, oncology, and respiratory diseases. Orion's customers include specialists and general practitioners, veterinarians, pharmacies, hospitals, and laboratories. Orion mainly serves Finland but also has a presence in other European countries, North America and other countries.
2006
3.7K+
LTM Revenue $1.7B
LTM EBITDA $571M
$7.6B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Orion has a last 12-month revenue of $1.7B and a last 12-month EBITDA of $571M.
In the most recent fiscal year, Orion achieved revenue of $1.7B and an EBITDA of $552M.
Orion expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Orion valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $1.3B | $1.7B | XXX | XXX | XXX |
| Gross Profit | $912M | $706M | XXX | XXX | XXX |
| Gross Margin | 71% | 43% | XXX | XXX | XXX |
| EBITDA | $353M | $552M | XXX | XXX | XXX |
| EBITDA Margin | 28% | 33% | XXX | XXX | XXX |
| Net Profit | $375M | $233M | XXX | XXX | XXX |
| Net Margin | 29% | 14% | XXX | XXX | XXX |
| Net Debt | n/a | $91.6M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, Orion's stock price is EUR 49 (or $53).
Orion has current market cap of EUR 6.9B (or $7.4B), and EV of EUR 7.0B (or $7.6B).
See Orion trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $7.6B | $7.4B | XXX | XXX | XXX | XXX | $2.57 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, Orion has market cap of $7.4B and EV of $7.6B.
Orion's trades at 4.5x LTM EV/Revenue multiple, and 13.2x LTM EBITDA.
Analysts estimate Orion's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Orion and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $7.6B | XXX | XXX | XXX |
| EV/Revenue | 4.6x | XXX | XXX | XXX |
| EV/EBITDA | 13.7x | XXX | XXX | XXX |
| P/E | 21.0x | XXX | XXX | XXX |
| P/E/Growth | 0.9x | XXX | XXX | XXX |
| EV/FCF | 34.1x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpOrion's NTM/LTM revenue growth is 10%
Orion's revenue per employee for the last fiscal year averaged $0.4M, while opex per employee averaged $0.2M for the same period.
Over next 12 months, Orion's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Orion's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Orion and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | 30% | XXX | XXX | XXX | XXX |
| EBITDA Margin | 33% | XXX | XXX | XXX | XXX |
| EBITDA Growth | 56% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | 43% | XXX | XXX | XXX | XXX |
| Revenue per Employee | $0.4M | XXX | XXX | XXX | XXX |
| Opex per Employee | $0.2M | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | 18% | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | 5% | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | 12% | XXX | XXX | XXX | XXX |
| Opex to Revenue | 34% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Julphar | XXX | XXX | XXX | XXX | XXX | XXX |
| Galapagos | XXX | XXX | XXX | XXX | XXX | XXX |
| Pharming | XXX | XXX | XXX | XXX | XXX | XXX |
| Vivoryon Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| Armata Pharmaceuticals | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Orion acquired XXX companies to date.
Last acquisition by Orion was XXXXXXXX, XXXXX XXXXX XXXXXX . Orion acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was Orion founded? | Orion was founded in 2006. |
| Where is Orion headquartered? | Orion is headquartered in Finland. |
| How many employees does Orion have? | As of today, Orion has 3.7K+ employees. |
| Who is the CEO of Orion? | Orion's CEO is Ms. Liisa Hurme, PhD. |
| Is Orion publicy listed? | Yes, Orion is a public company listed on HEL. |
| What is the stock symbol of Orion? | Orion trades under ORNAV ticker. |
| When did Orion go public? | Orion went public in 2006. |
| Who are competitors of Orion? | Similar companies to Orion include e.g. Julphar, Galapagos, Pharming, Vivoryon Therapeutics. |
| What is the current market cap of Orion? | Orion's current market cap is $7.4B |
| What is the current revenue of Orion? | Orion's last 12-month revenue is $1.7B. |
| What is the current EBITDA of Orion? | Orion's last 12-month EBITDA is $571M. |
| What is the current EV/Revenue multiple of Orion? | Current revenue multiple of Orion is 4.5x. |
| What is the current EV/EBITDA multiple of Orion? | Current EBITDA multiple of Orion is 13.2x. |
| What is the current revenue growth of Orion? | Orion revenue growth between 2023 and 2024 was 30%. |
| Is Orion profitable? | Yes, Orion is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
